Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.

Jingjing Duan; Lila Zhu; Yinghui Shi; Weixue Wang; Tongtong Wang; Tao Ning; Le Zhang; Ming Bai; Hongli Li; Rui Liu

doi:10.1186/s12885-024-12072-5

Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.

Identifier:nobleid.org/w1/20260515/7DA7C752

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7DA7C752.svg?ark=w1%2F20260515%2F7DA7C752)](https://nobleid.org/work/w1/20260515/7DA7C752)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.

Identifier:nobleid.org/w1/20260515/7DA7C752

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7DA7C752.svg?ark=w1%2F20260515%2F7DA7C752)](https://nobleid.org/work/w1/20260515/7DA7C752)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work